Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Marijuana is set to be reclassified as a lower-risk drug in the United States which will have wide-reaching implications for the cannabis sector. The Biden administration in 2022 ordered the initiation of a review of how marijuana is scheduled within the Controlled Substances Act.

Marijuana rescheduling set to bring tax relief, expanded investor base to cannabis operators

GrowGeneration Corp

Green Thumb Industries Inc.

Yesterday brought a significant rally for cannabis stocks as good news from Capitol Hill sent the entire sector into the green. The White House announced that plans to reschedule marijuana as a Schedule III substance are moving forward.

The 3 Best Cannabis Stocks to Buy Now as DEA Preps to Reclassify Marijuana

Curaleaf Holdings, Inc. (CURLF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Curaleaf Holdings, Inc. (CURLF) Surges 24.6%: Is This an Indication of Further Gains?

Cronos Group

Tilray Brands

Warren Buffett is a well-known proponent of value investing. The legendary investor waits for the right valuation before making a big plunge.

Stock Market Crash Alert: 3 Must-Buy Cannabis Stocks When Prices Plunge

Canopy Growth

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use as well.

3 Hot Cannabis Stocks With Multibagger Return Potential Before the Presidential Election

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose the lowering of cannabis to a Schedule III controlled substance. For more than 50 years, cannabis has been a Schedule I substance under federal law, in the same bucket as heroin and fentanyl.

Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA

Grana y Montero

As we head into another exciting week in the financial markets, marijuana stocks are drawing significant attention. Investors keen on tapping into the burgeoning U.S. cannabis industry, valued at around $33.6 billion in 2023, with projections reaching up to $53.5 billion by 2027, should keep an eye on these volatile yet potentially rewarding stocks. Notably, the industry continues to expand across medical and recreational fronts, driven by increasing legalization and acceptance. This week, examining specific market players through detailed technical analysis and applying rigorous risk management strategies will be crucial for investors aiming to navigate this high-growth but unpredictable sector.

Top Marijuana Stocks for May 2024: What to Watch

Altria

OrganiGram Holdings Inc.

As the cannabis market continues to expand globally, savvy investors are looking for top cannabis stocks to buy. The global legal cannabis market is projected to reach $58 billion by 2028, driven primarily by adult-use sales in the U.S., according to BDSA.

The Top 3 Cannabis Stocks to Buy in April 2024

It's been a wild journey for cannabis stocks in the last eight years. There have been phases of euphoria that have quickly fizzled out.

3 Cannabis Stocks That Could Be Multibaggers in the Making: April Edition

As we soon come to close out April marijuana stocks could see an upward push in trading. Right now it seems with all the politics surrounding cannabis reform there is an increase in speculation. There is no denying that the legal cannabis market is thriving on a major scale. What seems to be causing more issues to better profitability is taxes and regulations. Most legal states have high taxes that legal operators have to pay. Along with operating a legal business in a grey area with the need for improved state-level regulations.

3 Top Marijuana Stock Cannabis Investors Right Now

Bolsters Company's Advantage in Several Key Emerging Markets, including Australia, New Zealand, Germany, Poland and the United Kingdom NEW YORK , April 22, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc.  (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announced today the closing of its acquisition of  Northern Green Canada ("NGC") , a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification. The accretive acquisition amplifies the Company's strategic advantage in established European markets including Germany, Poland and the United Kingdom and provides a foothold in the emerging markets of Australia and New Zealand.

Curaleaf Completes Acquisition of Northern Green Canada

Cannabis culture is being celebrated today on “4/20” with weed lovers gathering at events to partake in the plant and enjoy retail promotions.   While the history of 4/20 is disputed, most trace it back to a group of students who attended San Rafael High School in California in the 1970s.

4/20 2024: Cannabis investors have much to celebrate this year

Tilray Brands and Canopy Growth are often the default options for investors looking for cannabis stocks. But those are risky, cash-burning businesses counting on the hopes that the U.S. legalizes marijuana soon.

The Best Cannabis Stock to Invest $1,000 in Right Now

The next two years can be make-or-break for the cannabis sector. The biggest speed bump to growth for cannabis companies is not competition, but regulations headwinds.

3 Cannabis Penny Stocks to Buy for 3-Bagger Returns

Investing in marijuana stocks can be difficult at times, especially with how fast things can change. Other sectors normally do not have as much volatility as cannabis does. Yet what keeps more people interested and invested in a sector with this type of uncertainty? Well as an industry legal cannabis is making a killing for the most part.

Here Are 3 Marijuana Stocks For You This Week

IAMGOLD

Joby Aviation

Penny stocks can be massive wealth creators. High-potential penny stocks that deliver 10x or 20x returns can have a huge impact on the overall portfolio.

3 High-Potential Penny Stocks to Turn $100,000 Into $1 Million: April 2024

Cannabis stocks could see higher highs. All thanks to recent legalization in Germany, the addition of a cannabis vote in Florida, growing approval ratings in polls, and speculation it could be favorably mentioned in the election.

Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for April 2024

NEW YORK , April 4, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2024 after market close on May 9, 2024. Management will host a conference call and audio webcast that afternoon at 5:00 p.m.

Curaleaf to Report First Quarter 2024 Financial and Operational Results

Over the last few years, cannabis stocks have struggled and trended lower. The two negatives being regulatory headwinds and cash burn.

The 3 Most Undervalued Cannabis Stocks to Buy in April 2024

The Florida Supreme Court on Monday ruled in favor of allowing Florida voters to decide whether cannabis can be sold to adults 21 and over through a referendum on the November ballot.

Florida Supreme Court OKs adult-use cannabis referendum for November ballot in victory for pot companies

Aurora Cannabis

What Cannabis Reform In Germany Means For North American Marijuana Companies

Cannabis stocks for your late March 2024 watchlist.

2 Cannabis Stocks To Watch In Late-March 2024

Appian

Cognex

Gildan Activewear

MasTec

Teradyne

Welltower

With the equities market continuing to march higher, now may be an ideal time to consider sleeper stocks. Essentially, these are companies that attract little interest among investors.

Wake Up to Wealth: 7 Sleeper Stocks Ready to Roar

In the last few years, cannabis stocks have been impacted by two factors. First, regulatory headwinds have played a spoilsport for an industry with huge potential.

3 Cannabis Stocks That Could Be Multibaggers in the Making: March Edition

Marijuana stock investors are looking to take profits any way they can. For some time much of the sector has lacked consistent momentum. Unless there is news or a catalyst big enough to move the sector. 2024 has a lot to offer the cannabis industry that could play out well for investors. More companies are working on many new projects and ventures. Some have partnered up with other companies and some have ramped up its current production with new products.

These Marijuana Stocks Could See Big Gains In 2024

News for Curaleaf Holdings, Inc. Stock (CURLF)